fosinopril has been researched along with Heart Failure in 38 studies
*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (57.89) | 18.2507 |
| 2000's | 15 (39.47) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Abboa-Offei, BE; Asaad, MM; Bednarz, MS; Chao, S; Cheung, HS; Cimarusti, MP; Dejneka, T; Fox, M; Mathers, PD; Misra, RN; Robl, JA; Ryono, DE; Schaeffer, TR; Seymour, AA; Simpkins, LM; Slusarchyk, WA; Smith, PL; Stevenson, J; Stratton, L; Sun, CQ; Trippodo, NC | 1 |
| Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A | 1 |
| Ma, Q; Ning, Y; Sun, M; Wu, S; Yang, L; Yang, T | 1 |
| Tereshchenko, SN; Zhirov, IV | 1 |
| Bicket, DP | 1 |
| Karkishchenko, NN; Makliakov, IuS; Sarbilina, IV | 1 |
| Lai, KN; Lam, KY; Leung, JC; Li, PS; Wing-Hon Lai, K; Yu, CM | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N | 1 |
| Berezin, AE | 1 |
| Cheng, XS; He, JG; Li, L; Li, YH; Liu, GZ; Ruan, YM; Wu, ZJ | 1 |
| Borghi, C; de Kam, PJ; Hochman, JS; van den Berg, MP; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Gao, J; He, H; Ma, L; Wang, P; Wang, W; Wu, H; Zhang, H | 1 |
| Aurigemma, GP; Douglas, PS; Katz, SE; Litwin, SE; Lorell, BH; Weinberg, EO | 1 |
| Blumenthal, M; Brown, EJ; Chew, PH; Gelperin, K; Ilgenfritz, JP; MacLean, A | 1 |
| Binder, SB | 1 |
| Ford, NF; Fulmor, IE; Hui, KK; Natarajan, C; Smith, RA | 1 |
| Delaney, C; Garland, WT; Kostis, JB; Liao, WC; Norton, J | 1 |
| Blumenthal, M; Erhardt, L; Gelperin, K; Ilgenfritz, J; MacLean, A | 1 |
| Bie, P; Emmeluth, C; Galatius-Jensen, S; Haunsø, S; Kastrup, J; Wroblewski, H | 1 |
| Berger, R; Dukat, A; Frey, B; Hülsmann, M; Koller-Strametz, J; Kos, T; Pacher, R; Stanek, B | 1 |
| Himeno, H; Hiroto, S; Minamisawa, K; Naruse, M; Shionoiri, H; Takasaki, I; Ueda, S | 1 |
| Coukell, A; Davis, R; McTavish, D | 1 |
| Giannattasio, C; Grassi, G; Mancia, G | 1 |
| Szucs, TD | 1 |
| Deedwania, PC | 1 |
| Blumenthal, M | 1 |
| Ambrosioni, E; Borghi, C; Collatina, S; Magnani, B; Marino, P; Zardini, P | 1 |
| Chati, Z; Guest, M; Plat, F; Zannad, F | 1 |
| Galatius, S; Haunsø, S; Kastrup, J; Nørgaard, T; Sørensen, V; Wroblewski, H | 1 |
| Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
| Caspi, A; Greenbaum, R; Liao, WC; Mangold, B; Nouriel, H; O'Grady, P; Paz, R; Sclarovsky, S; Yee, KF; Zucchelli, P | 1 |
| Cukon, S; Ennezat, PV; Hammer, A; Infeld, J; Jorde, UP; Le Jemtel, TH; Lisker, J; Sonnenblick, EH; Suryadevara, V | 1 |
| Blumenthal, M; Deitchman, D; Eni, JS; Gelperin, K; Ilgenfritz, JP; Sharma, S | 1 |
| Ayan, F; Eryonucu, B; Keser, N; Koldas, L; Sirmaci, A | 1 |
| Bonnet, F; Burrell, LM; Cao, Z; Cooper, ME; Gilbert, RE; Tikkanen, I | 1 |
| Burnett , JC; Chen, HH; Harty, GJ; Lainchbury, JG; Matsuda, Y | 1 |
9 review(s) available for fosinopril and Heart Failure
| Article | Year |
|---|---|
[Fosinopril in the treatment of cardiorenal syndrome in chronic cardiac failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Fosinopril; Heart Failure; Humans; Renal Insufficiency; Sympathetic Nervous System; Syndrome; Treatment Outcome | 2009 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
ACE inhibitors: review of four new agents.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Fosinopril; Heart Failure; Humans; Hypertension; Isoquinolines; Quinapril; Ramipril; Tetrahydroisoquinolines | 1993 |
Fosinopril. Clinical pharmacokinetics and clinical potential.
Topics: Absorption; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Interactions; Female; Fosinopril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Myocardial Ischemia; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1997 |
Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Fosinopril; Heart Failure; Hemodynamics; Humans | 1997 |
Treatment of heart failure with fosinopril: an angiotensin converting enzyme inhibitor with a dual and compensatory route of excretion.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Controlled Clinical Trials as Topic; Fosinopril; Heart Failure; Hemodynamics; Humans; Kidney; Liver; Matched-Pair Analysis; Pressoreceptors; Renin-Angiotensin System; Stroke Volume; Survival Rate; Sympathetic Nervous System | 1997 |
Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; Delivery of Health Care; Economics, Pharmaceutical; Fosinopril; Heart Failure; Hospital Charges; Humans; Ventricular Dysfunction, Left | 1997 |
The progression from hypertension to heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Disease Progression; Female; Fosinopril; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Middle Aged | 1997 |
Treatment of congestive heart failure: experience with fosinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Enalaprilat; Exercise Tolerance; Fosinopril; Half-Life; Heart Failure; Hemodynamics; Humans; Kidney; Kidney Diseases; Lisinopril; Male | 1997 |
13 trial(s) available for fosinopril and Heart Failure
| Article | Year |
|---|---|
[Plasma tissue factor and serum angiotensin II and the therapeutic effect of different dosages of fosinopril on chronic heart failure].
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Thromboplastin | 2009 |
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fibrinolytic Agents; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Recurrence; Risk Factors; Survival Analysis; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2005 |
Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group.
Topics: Aged; Chronic Disease; Diuretics; Double-Blind Method; Exercise Test; Female; Fosinopril; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Prospective Studies | 1995 |
Fosinopril: pharmacokinetics and pharmacodynamics in congestive heart failure.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Cross-Over Studies; Female; Fosinopril; Heart Failure; Humans; Injections, Intravenous; Male; Matched-Pair Analysis; Middle Aged; Prodrugs | 1995 |
Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Exercise Test; Fosinopril; Heart Failure; Hemodynamics; Humans; Prospective Studies; Treatment Outcome | 1995 |
Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Echocardiography; Endothelins; Exercise Test; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Regression Analysis | 1996 |
Effects of atenolol as add-on therapy to fosinopril in heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fosinopril; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pilot Projects; Stroke Volume; Ventricular Function, Left | 1997 |
Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cause of Death; Double-Blind Method; Drug Administration Schedule; Echocardiography; Female; Follow-Up Studies; Fosinopril; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Stroke Volume; Survival Rate; Thrombolytic Therapy; Tissue Plasminogen Activator | 1998 |
Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Fosinopril; France; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome | 1998 |
Reversal of peripheral microvascular dysfunction during long-term treatment with the angiotensin-converting enzyme inhibitor fosinopril in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Fosinopril; Heart Failure; Humans; Male; Microcirculation; Middle Aged; Muscle, Skeletal; Pressoreceptors; Regional Blood Flow; Time Factors; Vascular Resistance | 1999 |
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalaprilat; Female; Fosinopril; Heart Failure; Humans; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A; Time Factors | 2000 |
The hemodynamic effects of long-term ACE inhibition with fosinopril in patients with heart failure. Fosinopril Hemodynamics Study Group.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Female; Fosinopril; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies | 1999 |
Comparison of the first dose response of fosinopril and captopril in congestive heart failure: a randomized, double-blind, placebo controlled study.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged | 2001 |
16 other study(ies) available for fosinopril and Heart Failure
| Article | Year |
|---|---|
Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cardiovascular Agents; Cyclic GMP; Enzyme Inhibitors; Heart Failure; Hypertension; Macaca fascicularis; Neprilysin; Pyridines; Rats; Renin; Sodium; Thiazepines | 1997 |
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, Animal; Exercise Tolerance; Fosinopril; Glucosides; Heart Failure; Male; Myocardial Infarction; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
[Chronopharmacological approaches to the therapeutic prophylaxis of chronic cardiac insufficiency in type I diabetes mellitus].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Fosinopril; Glucose; Heart Failure; Hemodynamics; Humans; Immunologic Factors; Male; Oligopeptides; Ramipril; Time Factors | 2003 |
Normalization of renal aquaporin-2 water channel expression by fosinopril, valsartan, and combination therapy in congestive heart failure: a new mechanism of action.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Aquaporin 2; Aquaporins; Drug Therapy, Combination; Fosinopril; Gene Expression; Heart Failure; Kidney Cortex; Kidney Medulla; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2004 |
Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carbazoles; Cardiac Pacing, Artificial; Carvedilol; Clinical Trials as Topic; Europe; Fosinopril; Heart Failure; Humans; Meta-Analysis as Topic; Propanolamines | 2004 |
[Effect of fosinopril on the rate of neurohumoral and proinflammatory activation in patients with heart failure].
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Data Interpretation, Statistical; Echocardiography; Fosinopril; Heart Failure; Humans; Immunoenzyme Techniques; Middle Aged; Natriuretic Peptide, Brain; Radioimmunoassay; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
[Changes of collagen expression of pulmonary arteries and heart ventricles and intervention of fosinopril and losartan in rats with heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Collagen; Female; Fosinopril; Heart Failure; Heart Ventricles; Losartan; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2004 |
Fosinopril and carvedilol reverse hypertrophy and change the levels of protein kinase C epsilon and components of its signaling complex.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Carbazoles; Cardiomegaly; Carvedilol; Fosinopril; Heart Failure; Lung; Male; Myocardium; Propanolamines; Protein Kinase C-epsilon; Proteomics; Rats; Rats, Sprague-Dawley; Signal Transduction | 2006 |
Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Diastole; Echocardiography; Fosinopril; Heart Failure; Hemodynamics; Hypertension; Male; Rats; Rats, Wistar; Systole; Time Factors; Ventricular Function, Left | 1995 |
Invasive pharmacodynamics of fosinopril in patients with congestive heart failure.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Chromatography, High Pressure Liquid; Female; Fosinopril; Half-Life; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulmonary Wedge Pressure; Renin | 1995 |
[Fosinopril in the cardiovascular management of elderly patients].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Heart Failure; Humans; Hypertension; Hypertension, Renal; Male | 1996 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Fosinopril; Heart Failure; Humans; Lisinopril; Male; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Treatment Failure; Valine; Valsartan | 2000 |
Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Blood Pressure; Creatinine; Disease Models, Animal; Fosinopril; Glomerular Filtration Rate; Heart Failure; Hypertension, Renal; Kidney; Male; Nephrectomy; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renin; Thiazepines; Urea | 2001 |
Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dogs; Fosinopril; Glomerular Filtration Rate; Heart Failure; Male; Neprilysin; Polysaccharides; Protease Inhibitors; Pyridines; Receptors, Atrial Natriuretic Factor; Sodium; Thiazepines | 2001 |
Three new ACE inhibitors for hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Bridged Bicyclo Compounds; Drug Interactions; Fosinopril; Heart Failure; Humans; Hypertension; Prodrugs; Proline; Ramipril | 1991 |